96 related articles for article (PubMed ID: 8883015)
1. A study on regulating factors of plasma refilling during hemodialysis.
Iimura O; Tabei K; Nagashima H; Asano Y
Nephron; 1996; 74(1):19-25. PubMed ID: 8883015
[TBL] [Abstract][Full Text] [Related]
2. An index of plasma refilling in hemodialysis patients.
Tabei K; Nagashima H; Imura O; Sakurai T; Asano Y
Nephron; 1996; 74(2):266-74. PubMed ID: 8893140
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
[TBL] [Abstract][Full Text] [Related]
4. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
[TBL] [Abstract][Full Text] [Related]
5. Response of vasoactive substances to intermittent ultrafiltration in normotensive hemodialysis patients.
Heintz B; Königs F; Dakshinamurty KV; Kierdorf H; Gladziwa U; Kirsten R; Nelson K; Wieland D; Riehl J; Mann H
Nephron; 1993; 65(2):266-72. PubMed ID: 8247191
[TBL] [Abstract][Full Text] [Related]
6. Influence of hemodialysis on intravascular volume and vasoactive hormones.
Katzarski KS; Randmaa I; Bergström J
Clin Nephrol; 1999 Nov; 52(5):304-11. PubMed ID: 10584994
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
[TBL] [Abstract][Full Text] [Related]
8. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B
Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811
[TBL] [Abstract][Full Text] [Related]
9. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
Franz M; Woloszczuk W; Hörl WH
Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
[TBL] [Abstract][Full Text] [Related]
10. Relationship between filtration coefficients of microvasculature and levels of atrial natriuretic peptide or echocardiographic measurements.
Yashiro M; Watanabe H; Tomita M; Yamadori N; Muso E
Blood Purif; 2005; 23(6):431-9. PubMed ID: 16155375
[TBL] [Abstract][Full Text] [Related]
11. Plasma cGMP level as a marker of the hydration state in renal replacement therapy.
Lauster F; Heim JM; Drummer C; Fülle HJ; Gerzer R; Schiffl H
Kidney Int Suppl; 1993 Jun; 41():S57-9. PubMed ID: 8391608
[TBL] [Abstract][Full Text] [Related]
12. [Response of vasoactive substance to blood pressure changes during hemodialysis in uremic patients].
Witkowicz J; Kokot F; Irzyniec T; Chudek J; Ficek R
Pol Arch Med Wewn; 1999 Sep; 102(3):763-71. PubMed ID: 10949883
[TBL] [Abstract][Full Text] [Related]
13. [Modification of atrial natriuretic peptide (ANP) and cyclic GMP by hemofiltration and hemodialysis].
Eisenhauer T; Talartschik J; Quentin E; Kreutzfeldt W; Scheler F
Klin Wochenschr; 1988 Sep; 66(18):940-5. PubMed ID: 2846948
[TBL] [Abstract][Full Text] [Related]
14. Vascular refilling coefficient is not a good marker of whole-body capillary hydraulic conductivity in hemodialysis patients: insights from a simulation study.
Pstras L; Waniewski J; Lindholm B
Sci Rep; 2022 Sep; 12(1):15277. PubMed ID: 36088359
[TBL] [Abstract][Full Text] [Related]
15. Characterization of "refilling types" by continuous blood volume monitoring during hemodialysis.
Röckel A; Abdelhamid S; Fiegel P; Menth M; Walb D; Schneditz D
Kidney Int Suppl; 1993 Jun; 41():S67-9. PubMed ID: 8320948
[TBL] [Abstract][Full Text] [Related]
16. Plasma atrial natriuretic peptide and cyclic nucleotide levels before and after a marathon.
Lijnen P; Hespel P; M'Buyamba-Kabangu JR; Goris M; Lysens R; Vanden Eynde E; Fagard R; Amery A
J Appl Physiol (1985); 1987 Sep; 63(3):1180-4. PubMed ID: 2820919
[TBL] [Abstract][Full Text] [Related]
17. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
Elias AN; Vaziri ND; Pandian MR; Kaupke J
Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
[TBL] [Abstract][Full Text] [Related]
19. [Circadian changes of atrial natriuretic peptide, cyclic AMP, cyclic GMP, sodium, blood pressure and heart rate in normal subjects].
Xu CT; Wang YM
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):37-40. PubMed ID: 1326384
[TBL] [Abstract][Full Text] [Related]
20. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
